Submission Details
| 510(k) Number | K041817 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2004 |
| Decision Date | November 19, 2004 |
| Days to Decision | 136 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K041817 is an FDA 510(k) clearance for the WEST NILE DETECT IGM ELISA, a Elisa, Antibody, West Nile Virus (Class II — Special Controls, product code NOP), submitted by Inbios Intl., Inc. (Seattle, US). The FDA issued a Cleared decision on November 19, 2004, 136 days after receiving the submission on July 6, 2004. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3940.
| 510(k) Number | K041817 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2004 |
| Decision Date | November 19, 2004 |
| Days to Decision | 136 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | NOP — Elisa, Antibody, West Nile Virus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3940 |
| Definition | The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients. |